Home / Diagnostic Services / Publications & Resources / Almac Voice Almac Voice Diagnostic Services Resources Almac Voice Potential impact of IVDR on diagnostic testing in Europe – What are the implications for the pharmaceutical industry? Almac Voice A machine learning approach to detect FFPE artefacts leads to accurate estimation of tumour mutational burden from sequencing data without a matched normal Almac Voice The Important Role of Biostatistics in Clinical Trial Assay Validation: 4 Key Areas for Consideration Almac Voice The increasing uptake of RNA-Seq as the technology of choice in biomarker discovery Almac Voice Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial Almac Voice The Almac Advantage – Post-Brexit Northern Ireland IVD Landscape Almac Voice Cancer gene expression signatures: The Rise and Fall…and Rise? Almac Voice The increasing uptake of RNA-Seq as the technology of choice in biomarker discovery Almac Voice Almac Voice: An introductory guide to biomarkers, precision, personalised and stratified medicine Almac Voice NGS (Next Generation Sequencing) panels and patient tumour testing for stratified medicine
